Trial Profile
Effects of ivabradine IV versus placebo on haemodynamic parameters in patients with a low cardiac output syndrome following planned coronary artery bypass surgery and requiring positive inotropic treatment. A phase II, single blind, exploratory, multicentre study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Dobutamine
- Indications Coronary artery disease
- Focus Therapeutic Use
- Sponsors Servier
- 26 Apr 2017 Status changed from recruiting to completed.
- 24 Apr 2017 New trial record